Dr. Vivien Bonazzi Joins Deloitte With a Focus on Data Science in Biomedical Research
WASHINGTON, Nov. 20, 2019 /PRNewswire/ -- Deloitte announced today that Vivien Bonazzi, Ph.D., recently joined its government and public services practice as both a managing director and its chief biomedical data scientist for Deloitte Consulting LLP. In this position, Bonazzi will focus on helping federal agencies utilize data science methods, technologies and cyberinfrastructures to better understand and utilize biomedical data.
Previously, Bonazzi was a senior advisor in the Office of the Director at National Institutes of Health (NIH) as well as co-founder and leader of the NIH Data Commons. In her role, she focused on creating connections across all NIH institutes, other government agencies, nonprofit, and commercial organizations in the U.S. and internationally to create new ways to share, access, analyze, find and provide attribution to biomedical data and tools regardless of geographical location, size, or complexity of data in order to enable new biomedical discoveries.
“Dr. Bonazzi’s in-depth knowledge of NIH and her deep technical expertise related to data science and biomedical research bring unique qualifications to Deloitte, as we deepen our expertise in the space,” said Kevin Brault, principal, Deloitte & Touche LLP and federal health care leader.
Prior to NIH, Bonazzi held several roles in the private and nonprofit sector, including Celera Genomics and The Institute for Genomic Research.
“I’m thrilled to be joining Deloitte and continue to follow my passion for understanding how data science methods and technologies can be applied to biomedical data to yield a better understanding of biology,” said Bonazzi. “I’m looking forward to supporting agencies in their mission to utilize data science to better understand and use complex biomedical data.”
Bonazzi holds a Bachelor of Science degree from the University of Canberra, Australia, and a master’s degree and doctorate in biomedicine and computational biology from the University of Melbourne, Australia.
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 5,000 private and middle market companies. Our people work across the industry sectors that drive and shape today’s marketplace — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Our network of member firms spans more than 150 countries and territories. Learn how Deloitte’s more than 312,000 people worldwide make an impact that matters at www.deloitte.com.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.
View original content to download multimedia: http://www.prnewswire.com/news-releases/dr-vivien-bonazzi-joins-deloitte-with-a-focus-on-data-science-in-biomedical-research-300961470.html